Since disruptions in Cdkn2a are commonly observed in clinical MPNST samples, we postulate that acceleration of tumor onset in BALB/c mice may be partially due to disruption of this locus. The gene discussed is CDKN2A; the disease is malignant peripheral nerve sheath tumor.